Haemorrhagic bullous pyoderma gangrenosum following COVID-19 vaccination.

Hung, Y-T; Chung, W-H; Tsai, T-F; Chen, C-B

Hung, Y-T; Chung, W-H; Tsai, T-F; Chen, C-B.

Hung YT; Department of Dermatology, Chang Gung Memorial Hospital, Linkou, Taipei, and Keelung branches, Taoyuan, Taiwan.
Chung WH; Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Linkou branch, Taoyuan, Taiwan.
Tsai TF; Department of Dermatology, Chang Gung Memorial Hospital, Linkou, Taipei, and Keelung branches, Taoyuan, Taiwan.
Chen CB; Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Linkou branch, Taoyuan, Taiwan.

J Eur Acad Dermatol Venereol ; 36(8): e611-e613, 2022 08.

Article in English | MEDLINE | ID: covidwho-2263605

Subject(s)

COVID-19 Vaccines; COVID-19; Pyoderma Gangrenosum; Skin Diseases, Vesiculobullous; COVID-19/prevention & control; COVID-19 Vaccines/adverse effects; Hemorrhage; Humans; Pyoderma Gangrenosum/drug therapy; Pyoderma Gangrenosum/etiology; Vaccination

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Skin Diseases, Vesiculobullous / Pyoderma Gangrenosum / COVID-19 Vaccines / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: J Eur Acad Dermatol Venereol Journal subject: Dermatology / Sexually Transmitted Diseases Year: 2022 Document Type: Article Affiliation country: Jdv.18132

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google